Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00177294 · ClinicalTrials.gov registry record · Phase 4
Augmenting Antidepressant Treatment With Interpersonal Psychotherapy for Treating Late-life Depression
A Phase 4 study, sponsored by University of Pittsburgh.
- Completed
- Registry status
- Phase 4
- Development phase
- 319
- Enrollment target
NCT00177294 is a Phase 4 study that has completed, run by University of Pittsburgh. The registered enrollment target is 319 participants.
The verdict
NCT00177294, a Phase 4 study, has completed, sponsored by University of Pittsburgh.
- COMPLETED
- Registry status
- Phase 4
- Development phase
- 319 participants
- Enrollment target
Study Summary
This study will determine whether adding interpersonal psychotherapy to treatment with the antidepressant escitalopram will be more effective in reducing symptoms of depression than antidepressant medication alone.
Interventions
- DRUG Escitalopram
- BEHAVIORAL Interpersonal Psychotherapy
- BEHAVIORAL Clinical Monitoring
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 319 participants |
| Start Date | 2004-04 |
| Est. Completion | 2009-08 |
| Phase | Phase 4 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00177294
The ClinicalTrials.gov registry entry for NCT00177294 describes a study currently listed as completed, categorized as Phase 4. The registered enrollment target is 319 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Pittsburgh, which has 1,238 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 3 interventions - of which Escitalopram is the first listed.
NCT00177294 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00177294 about?
NCT00177294 is a clinical study titled "Augmenting Antidepressant Treatment With Interpersonal Psychotherapy for Treating Late-life Depression". This study will determine whether adding interpersonal psychotherapy to treatment with the antidepressant escitalopram will be more effective in reducing symptoms of depression than antidepressant medication alone.
What is the current status of trial NCT00177294?
This trial is currently completed. It is a Phase 4 study. The enrollment target is 319 participants. The study started on 2004-04. Estimated completion is 2009-08.
What interventions are being tested in trial NCT00177294?
The interventions under investigation include: Escitalopram (DRUG), Interpersonal Psychotherapy (BEHAVIORAL), Clinical Monitoring (BEHAVIORAL).
Who is sponsoring clinical trial NCT00177294?
This trial is sponsored by University of Pittsburgh, which has 1,238 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.